Potential interactions between drugs and valerian or garlic herbal medicines;Potenciais interações entre fármacos e produtos à base de valeriana ou alho

Revista Brasileira de Farmacognosia

Volumn 18, Issue 3, 2008, Pages 455-463

  Alexandre, Rodrigo F ^a   Bagatini, Fabíola ^a   Simões, Cláudia M O ^a  

^a Campus Trindade Universidade Federal de Santa Catarina   (Brazil)

Author keywords

Allium sativum; Garlic; Herb drug interactions; Liliaceae; Valerian; Valeriana officinalis; Valerianaceae

Indexed keywords

EID: 55849089254     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2008000300021     Document Type: Review

References (107)

1. Alder R, Lookinland S, Berry JA, Williams M 2003. A systematic review of the effectiveness of garlic as an anti-hyperlipidemic agent. Am Acad Nurse Pract 15: 120-129.
2. Alexandre RF, Bagatini F, Simões CMO 2008. Interações entre fármacos e medicamentos fitoterápicos à base de ginkgo e ginseng. Rev Bras Farmacogn 18: 117-126.
3. Ali M, Thomson M, Afzal M 2000. Garlic and onions: their effect on eicosanoid metabolism and its clinical relevance. Prostag Leukotr Essent Fatty Acids 62: 55-73.
4. Ariga T, Tsuj K, Seki T, Moritomo T, Yamamoto JI 2000. Antithrombotic and antineoplastic effects of phytoorganosulfur compounds. Biofactors 13: 251-255.
5. Ariga T, Seki T 2006. Anthrombotic and anticancer effects of garlic-derived sulfur compounds: a review Biofactors 26: 93-103.
6. Ashraf MZ, Hussain ME, Fahim M 2004. Endothelium mediated vasorelaxant response of garlic in isolated rat aorta: role of nitric oxide. J Ethnopharmacol 90: 5-9.
7. Aslam M, Stockley IH 1979. Interaction between curry ingredient (karela) and drug (chlorpropamide). Lancet 1: 607.
8. Augusti KT 1996. Therapeutic values of onion (Allium cepa L.) and garlic (Allium sativum L.). Indian J Exp Biol 34: 634-640.
9. Augusti KT, Sheela CG 1996. Antiperoxide effect of S-allyl cysteine sulfoxide, an insulin secretagogue, in diabetic rats. Experientia 52: 115-120.
10. Baillard C, Bianchi A, Gehan G, Sitbon P, Denantes C, Benhamou D, Cupa M, Samama CM 2007. Anaesthetic preoperative assessment of chronic medications and herbal medicine use: a multicenter survey. Ann Fr Anesth Reanim 26: 132-135.
11. Bent S, Padula A, Moore D, Patterson M, Mehling W 2006. Valerian for sleep: a systematic review and meta-analysis. Am J Med 119: 1005-1012.
12. Block E 1985. The chemistry of garlic and onions. Sci Am 252: 114-119.
13. Blumenthal M, Goldberg A, Brinckmann J 2000. Herbal Medicine: Expanded commission e monographs. Austin: American Botanical Council 139-148.
14. Blumenthal M 2003. The ABC clinical guide to herbs. Austin: American Botanical Council 153-170.
15. Blumenthal M, Ferrier GKL, Cavaliere C 2006. Total sales of herbal supplements in United States show steady growth. HerbalGram 71: 64-66.
16. Bordia A, Verma SK, Srivastava KC 1998. Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostag Leukotr Essent Fatty Acids 58: 257-63.
17. Brandão MGL, Cosenza GP, Moreira RA, Monte-Mor RLM 2006. Medicinal plants and other botanical products from the Brazilian Official Pharmacopoeia. Rev Bras Farmacogn 16: 408-420.
18. Brandão MGL, Zanetti NNS, Oliveira GRR, Goulart LO, Monte-Mor RLM 2008. Other medicinal plants and botanical products from the first edition of the Brazilian Official Pharmacopoeia. Rev Bras Farmacogn 18: 127-134.
19. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT 2000. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7: 273-282.
20. Capasso A, Defeo V, Desimon F, Sorrentino L 1996. Pharmacological effects of aqueous extracts from Valeriana adscents. Physiother Res Int 10: 309-312.
21. Carden SM, Good WV, Carden PA, Good RM 2002. Garlic and the strabismus surgeon. Clin Exp Ophthalmol 30: 303-304.
22. Carvalho ACB, Balbino EE, Maciel A, Perfeito JPS 2008. Situação do registro de medicamentos fitoterápicos no Brasil. Rev Bras Farmacogn 18: 314-319.
23. Cavadas C, Araujo I, Ctrim MD, Amaral T, Cunha AP, Macedo T, Ribeiro CF 1995. In vitro study on the interaction of Valeriana officinalis L. extracts and their aminoacids on GABAa receptor in rat brain. Arzneimittel-Forsch 45: 753-755.
24. Chavez ML, Jordan MA, Chavez PI 2006. Evidence-based drug-herbal interactions.Life Sci 78: 2146-2157.
25. Chen HW, Yang JJ, Tsai CW, Wu JJ, Sheen LY, Ou CC, Lii CK 2001. Dietary fat and garlic oil independently regulate hepatic cytochrome p(450) 2B1 and the placental form of glutathione S-transferase expression in rats. J Nutr 131: 1438-1443.
26. Chen HW, Tsai CW, Yang JJ, Liu CT, Kuo WW, Lii CK 2003. The combined effects of garlic oil and fish oil on the hepatic antioxidant and drug-metabolizing enzymes of rats. Brit J Nutr 89: 189-200.
27. Cordeiro CHC, Chung MC, Sacramento LVS 2005. Interações medicamentosas de fitoterápicos e fármacos: Hypericum perforatum e Piper methysticum. Rev Bras Farmacogn 15: 272-278.
28. Dalvi RR 1992. Alterations in hepatic phase I and phase II biotransformation enzymes by garlic oil in rats. Toxicol Lett 60: 299-305.
29. Das I, Khan NS, Sooranna SR 1995. Potent activation of nitric oxide synthase by garlic: a basis for its therapeutic applications. Curr Med Res Opin 13: 257-263.
30. Dausch JG, Nixon DW 1990. Garlic: a review of its relationship to malignant disease. Prev Med 19: 346-361.
31. Donovan JL, DeVane CL, Chavin KD, Wang JS, Gibson BB, Gefroh HA, Markowitz JS 2004. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metab Dispos 32:1333-1336.
32. Ernst E 2000a. Possible interactions between synthetic and herbal medicinal products Part 1: a systematic review of the indirect evidence. Perfusion 13: 4-15.
33. Ernst E 2000b. Interactions between synthetic and herbal medicinal products Part 2: a systematic review of the direct evidence. Perfusion 13: 60-70.
34. Foster BC, Foster MS, Vandenhoek S, Krantis A, Budzinski JW, Arnason JT, Gallicano KD, Choudri S 2001. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharm Sci 4: 176-184.
35. Fugh-Berman A 2000. Herb-drug interactions. Lancet 355: 134-138.
36. Fugh-Bernman A, Ernst E 2001. Herb-drug interactions: review and assessment of report reability. Brit J Clin Pharmacol 52: 587-595.
37. Fukao H, Yoshida H, Tazawa Y, Hada T 2007. Antithrombotic effects of odorless garlic powder both in vitro and in vivo. Biosci Biotechnol Biochem 71: 84-90.
38. Gallicano K, Foster B, Choudhri S 2003Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. J Clin Pharmacol 55: 199-202.
39. German K, Kumar U, Blackford HN 1995. Garlic and the risk of TURP bleeding. Brit J Urol 76: 518.
40. Groppo F, Ramacciato J, Motta R, Ferraresi P, Sartoratto A 2007. Antimicrobial activity of garlic against oral streptococci. Int J Dent Hyg 5: 109-115.
41. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CYW 2002. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 72: 276-287.
42. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A 2005a. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 77: 415-426.
43. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY 2005b. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drug Aging 22: 525-539.
44. Gyllenhaal C, Merritt SL, Peterson SD, Block KL, Gochenour T 2000. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med Rev 4: 229-251.
45. Gwilt PR, Lear CL, Tempero MA, Birt DD, Grandjean AC, Ruddon RW, Nagel DL 1994. The effect of garlic extract on human metabolism of acetaminophen. Cancer Epidemiol Biomarkers Prev 3: 155-160.
46. Hadley S, Petry JJ 2003. Valerian. Am Fam Physician 67: 1755-1758.
47. Harris JC, Cottrell SL, Plummer S, Lloyd D 2001. Antimicrobial properties of Allium sativum (garlic). Appl Microbiol Biotechnol 57: 282-286.
48. Hellum BH, Hu Z, Nilsen OG 2007. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic Clin Pharmacol Toxicol 100: 23-30.
49. Hendriks H, Bos R, Woerdenbag HJ, Koster AS 1985. Central nervous depressant activity of valerenic acid in the mouse. Planta Med 1: 28-31.
50. Hiller KO, Zetler G 1996. Neuropharmacological studies on ethanol extracts of Valeriana officinalis L.: behavioural and anticonvulsivant activity. Phytother Res 10: 145-151.
51. Houghton P 1988. The biological activity of valerian and related plants. J Ethnopharmacol 22: 121-142.
52. Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL, Zhou S 2005. Herb-drug interactions: a literature review. Drugs 65: 1239-1282.
53. Izzo AA, Ernst E 2001. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61: 2163-2175.
54. Izzo AA 2004. Herb-drug interactions: an overview of the clinical evidence. Fund Clin Pharmacol 19: 1-16.
55. Kannar D, Wattanapenpaiboon N, Savige GS, Wahlqvist ML 2001. Hypocholesterolemic effect of an enteric-coated garlic supplement. J Am Coll Nutr 20: 225-231.
56. Khawaja IS, Marotta RF, Lippmann S 1999. Herbal medicines as a factor in delirium. Psychiatr Serv 50: 969-970.
57. Kiss ACI, Takaku M, Damasceno DC, Campos KE, Sinzato YK, Lima PO, Volpato GT 2006. Efeito do extrato aquoso de Allium sativum L. sobre parâmetros bioquímicos de ratas com diabete induzido por Streptozotocin. Rev Bras Pl Med 8: 24-30.
58. Kojuri J, Vosoughi AR, Akrami M 2007. Effects of Anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis 6: 1-5.
59. Kyo E, Uda N, Kasuga S, Itakura Y 2001. Immunomodulatory effects of aged garlic extract. J Nutr 131: 1075S-1079S.
60. Lanzotti V 2006. The analysis of onion and garlic. J Chromatogr A 1112: 3-22.
61. Laroche M, Choudhri S, Gallicano K 1998. Severe gastrointestinal toxicity with concomitant ingestion of ritonavir and garlic. Can J Infect Dis 35: 275-291.
62. Leathwood PD, Chauffard F, Heck E, Munoz-Box R 1982. Aqueous extract of valerian root (Valerian officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav 17: 65-71.
63. Lefebvre T, Foster BC, Drouin CE, Krantis A, Livesey JF, Jordan SA 2004. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J Pharm Pharm Sci 7: 265-273.
64. Leuschner J, Müller J, Rudmann M 1993. Characterisation of the central nervous depressant activity of a commercially available valerian root extract. Arzneimittel-Forsch 43: 638-641.
65. Lii CK, Tsai CW, Wu CC 2006. Garlic allyl sulfides display differential modulation of rat cytochrome P450 2B1 and the placental form glutathione S-transferase in various organs. J Agric Food Chem 54: 5191-5196.
66. Lin MC, Wang EJ, Patten C, Lee MJ, Xiao F, Reuhl KR, Yang CS 1996. Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice. J Biochem Toxicol 11: 11-20.
67. Lindhal O, Lindwall L 1989. Double blind study of a valerian preparation. Pharmacol Biochem Behav 32: 1065-1066.
68. MacDonald JA, Langler RF 2000. Structure-activity relationships for selected sulfur-rich antithrombotic compounds. Biochem Biophys Res Commun 273: 421-424.
69. MacDonald JA, Marchand ME, Langler RF 2004. Improving upon the in vitro biological activity of antithrombotic disulfides. Blood Coagul Fibrinolysis 15: 447-450.
70. Markowitz JS, Devane CL, Chavin KD, Taylor RM, Ruan Y, Donovan JL 2003. Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin Pharmacol Ther 74: 170-177.
71. Maslin, DJ, Brown CA, Das I, Xia-Hua Z 1997. Nitric oxide a mediator of garlic action? Biochem Soc Trans 25: 408s.
72. Mccoubrie M 1996. Doctors as patients: lisinopril and garlic. Brit J Gen Pract 46: 107.
73. Micromedex 2006. Drug-Reax Interactive Drug Interactions: Valerian 2006. http://cdrompro.com.br/micromedex/trial.html, acessada em: 27 de abril de 2007.
74. Mills E, Wu P, Johnston BC, Gallicano K, Clarke M, Guyatt G 2005a. Natural health product-drug interactions: a systematic review of clinical trials. Ther Drug Monit 27: 549-557.
75. Mills E, Montori V, Perri D, Phillips E, Koren G 2005b. Natural health product-HIV drug interactions: a systematic review Int J STD AIDS 16: 181-186.
76. Neil HA, Silagy CA, Lancaster T, Hodgeman J, Vos K, Moore JW, Jones L, Cahill J, Fowler GH 1996. Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. J R Coll Physicians Lond 30: 329-34.
77. Oliveira FQ, Gobira B, Guimarães C, Batista J, Barreto M, Souza M 2007. Espécies vegetais indicadas na odontologia. Rev Bras Farmacogn 17: 466-476.
78. Pal D, Mitra AK 2006. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci 78: 2131-2145.
79. Patel J, Buddha B, Dey S, Pal D, Mitra AK 2004. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Am J Ther 11: 262-277.
80. Petry JJ 1995. Garlic and postoperative bleeding. Plast Reconstr Surg 96: 483-484.
81. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J 2002. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 34: 234-238.
82. Ribeiro AQ, Leite JPV, Dantas-Barros AM 2005. Perfil de utilização de fitoterápicos em farmácias comunitárias de Belo Horizonte sob a influência da legislação nacional. Rev Bras Farmacogn 15: 65-70.
83. Rose KD, Croissant PD, Parliament CF, Levin MB 1990. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report Neurosurgery 26: 880-882.
84. Sallam KI, Ishioroshi M, Samejima K 2004. Antioxidant and antimicrobial effects of garlic in chicken sausage. Lebenson Wiss Technol 37: 849-855.
85. Santos MS, Ferreira F, Faro C, Cunha AP, Pires E, Carvalho AP, Macedo T 1994a. The amount of GABA present in aqueous extracts of valerian is sufficient to account for [3H] GABA release in synaptossomes. Planta Med 60: 475-476.
86. Santos MS, Ferreira F, Faro C, Cunha AP, Pires E, Carvalho AP, Macedo T 1994b. An aqueous extract of valerian influences the transports of GABA in synaptossomes. Planta Med 60: 278-279.
87. Saw JT, Bahari MB, Ang HH, Lim YH 2006. Potential drug-herb interaction with antiplatelet/anticoagulant drugs. Complement Ther Clin Pract 12: 236-241.
88. Schulz V, Hänsel R, Tyler VE 2001. Rational phytotherapy: a physicians' guide to the herbal medicine. 4. ed. Berlin: Springer, p. 57-77.
89. Sheela CG, Augusti KT 1992. Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn. Indian J Exp Biol 30: 523-526.
90. Sheela CG, Kumud K, Augusti KT 1995. Anti-diabetic effects of onion and garlic sulfoxide amino acids in rats. Planta Med 61: 356-357.
91. Silagy C, Neil A 1994. Garlic as a lipid lowering agent-a meta-analysis. J R Coll Physicians Lond 28: 39-45.
92. Sooranna SR, Hirani J, Das I 1995. Garlic induce both GTP cyclohydrase and nitric oxide synthase activity in choriocarcinoma cells. Biochem Soc Trans 23: 543s.
93. Sparreboom A, Cox MC, Acharya MR, Figg WD 2004. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 22: 2489-2503.
94. Spinella M 2002. The importance of pharmacological synergy in psychoative herbal medicines. (Herbal synergy review). Altern Med Rev 7: 130-138.
95. Stevinson C, Pittler MH, Ernst E 2000. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 133: 420-429.
96. Sunter WH 1991. Warfarin and garlic. Pharm J 246: 772.
97. Tattelman E 2005. Health effects of garlic. Am Fam Physician 72: 103-106.
98. Tesch BJ 2003. Herbs commonly used by women: an evidence-based review. Am J Obstet Gynecol 188(5 Suppl): S44-S55.
99. Ugalde M, Reza V, Gonzalez-Trujano ME, Avula B, Khan IA, Navarrete A 2005. Isobolographic analysis of the sedative interaction between six central nervous system depressant drugs and Valeriana edulis hydroalcoholic extract in mice. J Pharm Pharmacol 57: 631-639.
100. Valli G, Giardina EG 2002. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J Am Coll Cardiol 39: 1083-1095.
101. van den Bout-van den Beukel CJ, Koopmans PP, van der Ven AJ, De Smet PA, Burger DM 2006. Possible drugmetabolism interactions of medicinal herbs with antiretroviral agents. Drug Metab Rev 38: 477-514.
102. Warshafsky S, Kamer RS, Sivak SL 1993. Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med 119: 599-605.
103. Wheatley D 2005. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J Psychopharmacol 19: 414-421.
104. Williamson EM 2003. Drug interactions between herbal and prescription medicines. Drug Saf 26: 1075-1092.
105. Williamson EM 2005. Interactions between herbal and conventional medicines 2005. Expert Opin Drug Saf 4: 355-378.
106. Wojcikowski K, Myers S, Brooks L 2007. Effects of garlic oil on platelet aggregation: a double blind placebo controlled crossover study. Platelets 18: 29-34.
107. Zhang XH, Lowe D, Giles P, Fell S, Connock MJ, Maslin DJ 2001. Gender may affect the action of garlic oil on plasma cholesterol and glucose levels of normal subjects. J Nutr 131: 1471-1478.